menu search

MTNB / Matinas BioPharma to Present at the JMP Securities Life Sciences Conference on May 15, 2023

Matinas BioPharma to Present at the JMP Securities Life Sciences Conference on May 15, 2023
BEDMINSTER, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that Jerome D. Jabbour, Chief Executive Officer, will present a company overview at the JMP Securities Life Sciences Conference on Monday, May 15, 2023 at 9:30 a.m. Eastern time. The conference is being held at the New York Hilton Midtown. Read More
Posted: May 11 2023, 07:30
Author Name: GlobeNewsWire
Views: 092129

MTNB News  

Matinas BioPharma to Present at Two Investment Conferences in October 2023

By GlobeNewsWire
September 28, 2023

Matinas BioPharma to Present at Two Investment Conferences in October 2023

BEDMINSTER, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on re more_horizontal

Matinas BioPharma to Present at the JMP Securities Life Sciences Conference on May 15, 2023

By GlobeNewsWire
May 11, 2023

Matinas BioPharma to Present at the JMP Securities Life Sciences Conference on May 15, 2023

BEDMINSTER, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on deli more_horizontal

Matinas Biopharma Holdings, Inc. (MTNB) Reports Q1 Loss, Tops Revenue Estimates

By Zacks Investment Research
May 10, 2023

Matinas Biopharma Holdings, Inc. (MTNB) Reports Q1 Loss, Tops Revenue Estimates

Matinas Biopharma Holdings, Inc. (MTNB) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to more_horizontal

Matinas BioPharma Holdings, Inc. (MTNB) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 15, 2023

Matinas BioPharma Holdings, Inc. (MTNB) Q4 2022 Earnings Call Transcript

Matinas BioPharma Holdings, Inc. (NYSE:MTNB ) Q4 2022 Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Jody Cain - Investor Rel more_horizontal

Matinas BioPharma Holdings, Inc. (MTNB) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 2, 2022

Matinas BioPharma Holdings, Inc. (MTNB) Q3 2022 Earnings Call Transcript

Matinas BioPharma Holdings, Inc. (NYSE:MTNB ) Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET Company Participants Ankit Bhargava - Invest more_horizontal

Matinas BioPharma (MTNB) CEO, Jerome Jabbour on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 12, 2022

Matinas BioPharma (MTNB) CEO, Jerome Jabbour on Q1 2022 Results - Earnings Call Transcript

Matinas BioPharma Holdings Inc. (NYSE:MTNB ) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Jerome Jabbour - Chief Exec more_horizontal

Matinas BioPharma Inks mRNA-Based Vaccine Pact With BioNTech

By Benzinga
April 11, 2022

Matinas BioPharma Inks mRNA-Based Vaccine Pact With BioNTech

BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have entered into an exclusive research collaboration to evaluate the more_horizontal


Search within

Pages Search Results: